SLC5A2 and type 2 diabetes mellitus: On the contrary, polymorphisms in the SLC5A2 gene (encoding SGLT2) were found to be associated with very small reductions in the incidence of HF and T2DM (both <3% relative risk reduction), whereas all-cause mortality was unaffected [53].